8-K: Ardent Health Reports Solid First Quarter 2025 Results, Reaffirms Full-Year Guidance

Ardent Health Partners, Inc. announced its first quarter 2025 financial results, reporting revenue growth and reaffirming its full-year 2025 guidance.

Summary

• Ardent Health Partners reported its first quarter 2025 results, with total revenue reaching $1.50 billion, a 4.0% increase year-over-year.
• Net income attributable to Ardent Health was $41 million, or $0.29 per diluted share.
• Adjusted EBITDA grew by 2.5% year-over-year to $98 million.
• The company reaffirmed its 2025 guidance, projecting total revenue between $6.20 billion and $6.45 billion and adjusted EBITDA between $575 million and $615 million.
• Admissions increased by 7.6% year-over-year, while adjusted admissions grew by 2.7%.
• Net patient service revenue per adjusted admission increased by 1.2% year-over-year.
• The company's net leverage ratio was 1.4x, and its lease-adjusted net leverage ratio was 3.0x as of March 31, 2025.
• Available liquidity at the end of the first quarter was $790 million.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting revenue growth, increased admissions, and reaffirmed guidance. While there are some challenges and risks mentioned, the overall tone is optimistic and suggests confidence in the company's future performance.

Positives

• Ardent Health achieved a 4.0% year-over-year increase in total revenue, reaching $1.50 billion.
• Net income attributable to Ardent Health increased to $41 million, or $0.29 per diluted share.
• Adjusted EBITDA grew by 2.5% year-over-year to $98 million.
• The company reaffirmed its full-year 2025 guidance, indicating confidence in its performance.
• Admissions increased by 7.6% year-over-year, reflecting strong demand for services.
• Inpatient surgeries increased 3.4% year-over-year, driven by improved transfer center operations.
• Supply costs saw a 60 basis point year-over-year reduction as a percentage of revenue.
• The company has $790 million in available liquidity.

Negatives

• Outpatient surgeries decreased by 2.3% year-over-year.
• Net cash used in operating activities increased to $25 million compared to $15 million in the same prior year period.
• First quarter results do not include any benefit from the New Mexico state directed payment program, which is currently awaiting approval from the Centers for Medicare & Medicaid Services.

Risks

• The company's forecasted guidance is subject to a number of known and unknown uncertainties and risks, including general economic conditions, changes in healthcare policy, and competition.
• The company faces risks related to potential reductions in Medicare, Medicaid, and other state programs.
• Security threats and catastrophic events could disrupt the company's IT systems and operations.
• The company's facilities are heavily concentrated in Texas and Oklahoma, making it sensitive to regulatory and economic changes in those states.
• The company is exposed to risks associated with its joint ventures.

Future Outlook

Ardent Health reaffirmed its full-year 2025 financial guidance, projecting total revenue between $6.20 billion and $6.45 billion and adjusted EBITDA between $575 million and $615 million.

Management Comments

• 'Ardent delivered solid first quarter 2025 results that reflect the successful execution of our strategic priorities and put us on track to meet our full-year financial targets,' stated Marty Bonick, President and Chief Executive Officer of Ardent Health.
• Marty Bonick noted that strong underlying volumes and a heightened flu season drove a 7.6% increase in admissions.
• Marty Bonick stated that the company continues to make progress executing on its strategic growth initiatives.
• Marty Bonick mentioned that inpatient volumes were solid with inpatient surgeries increasing 3.4% driven by improved transfer center operations.
• Marty Bonick stated that the company is driving ambulatory growth with the integration of the NextCare urgent care assets.
• Marty Bonick noted that a disciplined focus on operational excellence resulted in a 60 basis point year-over-year reduction in supply costs and a moderation in professional fee expense growth.
• Marty Bonick added that the company is evaluating a growing pipeline of attractive inorganic growth opportunities and continues to see strong interest in its unique joint venture model.

Industry Context

Ardent Health's focus on growing mid-sized urban communities aligns with the broader industry trend of expanding healthcare access in underserved areas. The company's emphasis on strategic growth initiatives and operational excellence reflects the increasing pressure on healthcare providers to improve efficiency and profitability in a competitive market.

Comparison to Industry Standards

• HCA Healthcare, a leading hospital operator, reported similar trends in admissions growth, indicating a broader recovery in patient volumes across the industry.
• Tenet Healthcare, another major player, is also focused on expanding its ambulatory care network, mirroring Ardent's strategy with NextCare.
• Ardent's lease-adjusted net leverage ratio of 3.0x is comparable to other hospital operators with significant leased real estate portfolios, such as Medical Properties Trust (MPT) and Ventas, Inc.

Stakeholder Impact

• Shareholders can expect continued focus on long-term value creation through strategic growth and operational efficiency.
• Employees will be impacted by ongoing restructuring and integration efforts.
• Patients should benefit from improved access to care and innovative services.
• Suppliers may experience changes in procurement practices as the company focuses on cost reduction.
• Creditors will be interested in the company's ability to manage its debt and maintain liquidity.

Next Steps

• The company will continue to execute its strategic growth initiatives, including integrating NextCare urgent care assets.
• Ardent Health will evaluate a growing pipeline of attractive inorganic growth opportunities.
• The company will focus on operational excellence to further reduce costs and improve efficiency.
• The company will monitor and respond to changes in healthcare policy and regulations.

Key Dates

Keywords

Ardent Health, financial results, healthcare, EBITDA, revenue, admissions, guidance